Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs
โ Scribed by Sreenivasa R. Vanapalli; Ya-Ping Hung; Lawrence Fleckenstein; Michael T. Dzimianski; John W. McCall
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 130 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.313
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A single-blind study was conducted in 10 healthy male subjects. Each subject was tested with four single oral doses of capsules containing 25, 50, 100, 200mg almitrine bismesylate and one dose of placebo. Blood samples were drawn as a function of time and the concentration of almitrine in plasma was
The pharmacokinetics of a new serotonin 5-HT 2 antagonist, deramciclane, was studied. Single oral doses of 1, 3, 6 and 10 mg kg -1 and intravenous doses of 1, 3 and 6 mg kg -1 were administered in beagle dogs. Moreover, the steady state pharmacokinetics of 1, 3 and 6 mg kg -1 doses were studied. Der
An adaption of a published high performance liquid chromatographic (HPLC) assay for phenylpropanolamine (PPA) in plasma was used to examine PPA pharmacokinetics in dogs. Plasma was extracted into ethyl acetate after the addition of 3.5 per cent sodium carbonate, and was then back-extracted into aque
## Abstract The pharmacokinetics of HIโ6 were studied following intravenous administration to beagle dogs (__n__ = 7). The bioavailability of two different strength intramuscularly administered doses was also determined in the same animals. After a 20 mg kg^โ1^ intravenous dose, the mean (ยฑS.D.) in